ArticleChildren (Basel, Switzerland)2025
Predicting Bloodstream Infection in Pediatric Post-Transfusion Febrile Neutropenia: Development of a Simple Bedside Risk Score.
Article in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesChildren receiving chemotherapy are highly susceptible to infection, and bloodstream infection (BSI) is a major cause of morbidity in febrile neutropenia. Post-transfusion fever represents a specific diagnostic dilemma, where febrile non-hemolytic transfusion reactions may be clinically indistinguishable from early BSI. We aimed to develop and internally validate a simple bedside score to predict BSI in children presenting to the ED with post-transfusion fever.
methodsWe performed a retrospective, single-center diagnostic prediction study of consecutive ED encounters between 2015 and 2024 in a tertiary children's hospital. Eligible encounters involved patients ≤ 18 years with an underlying malignancy receiving systemic chemotherapy who presented with fever within 24 h of red blood cell or platelet transfusion, had neutropenia, and with at least one blood culture obtained. BSI was defined as growth of a clinically significant pathogen within 48 h; episodes with only contaminants or colonizing flora were classified as non-BSI. Multivariable logistic regression with four prespecified predictors-transfusion-to-ED arrival interval, body temperature, absolute neutrophil count (ANC), and C-reactive protein (CRP)-was used to develop the model and derive a 0-5 point bedside score. Performance was assessed using AUC, diagnostic indices at prespecified cut-offs, calibration, and bootstrap internal validation.
resultsOf 507 screened encounters, 287 met inclusion criteria; 39 (13.6%) were adjudicated as BSI. The full model showed good discrimination (AUC 0.82). The derived score (2 points for ANC = 0/µL; 1 point each for temperature ≥ 38.5 °C, CRP ≥ 2.5 mg/dL, and transfusion-to-ED interval ≥ 7 h) achieved an AUC of 0.84. At a cut-off ≥2, sensitivity was 97.4% and negative predictive value 98.8%, misclassifying 1 of 39 BSIs as low risk; at ≥3, specificity was 59.7% with sensitivity 89.7%. Bootstrap-corrected AUC was 0.83.
conclusionsIn children receiving chemotherapy who present with post-transfusion fever, a simple 0-5 point bedside score based on temperature, ANC, CRP, and transfusion-to-ED interval provided useful early stratification of BSI risk in this single-center cohort. Prospective multicenter validation is needed before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.